On Monday, there was a debate in the UK Parliament on Covid vaccine safety. Cast into shadow by a storm of reporting on the appointment of the UK’s latest Prime Minister, it received virtually no mainstream press attention. This is unfortunate, as the issues it raises – about the scale of adverse vaccine reactions, excess death trends, potential breaches of medical ethics, and regulatory capture – are deserving of both airtime and urgent investigation.
In the UK as elsewhere the scale of adverse reactions from the Covid-19 vaccine is bitterly contested. The Parliamentary debate was no different – on the one hand Elliot Colburn (MP) repeated the orthodoxy that serious adverse events were “incredibly rare” and that such events as are reported are “typically mild, with individuals usually recovering within a short time;” whilst others cited evidence which casts doubt on that official narrative.
Sir Christopher Chope (MP) pointed out that other data sets have put risks much higher than the “12 reports per 1 million doses” pinpointed by Colburn as the Pfizer-suspected myocarditis reporting rate – “The Paul Ehrlich Institute is the German regulator responsible for vaccine safety,” he explained, before noting that on 20 July 2022, “…the institute confirmed that one in 5,000 people was seriously affected after a vaccination.”
Join the conversation as a VIP Member